Genes (Sep 2021)

Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients

  • Elisabetta Vergani,
  • Simona Frigerio,
  • Matteo Dugo,
  • Andrea Devecchi,
  • Erika Feltrin,
  • Loris De Cecco,
  • Viviana Vallacchi,
  • Mara Cossa,
  • Lorenza Di Guardo,
  • Siranoush Manoukian,
  • Bernard Peissel,
  • Andrea Ferrari,
  • Gianfrancesco Gallino,
  • Andrea Maurichi,
  • Licia Rivoltini,
  • Marialuisa Sensi,
  • Monica Rodolfo

DOI
https://doi.org/10.3390/genes12091440
Journal volume & issue
Vol. 12, no. 9
p. 1440

Abstract

Read online

The MITF-E318K variant has been implicated in genetic predisposition to cutaneous melanoma. We addressed the occurrence of MITF-E318K and its association with germline status of CDKN2A and MC1R genes in a hospital-based series of 248 melanoma patients including cohorts of multiple, familial, pediatric, sporadic and melanoma associated with other tumors. Seven MITF-E318K carriers were identified, spanning every group except the pediatric patients. Three carriers showed mutated CDKN2A, five displayed MC1R variants, while the sporadic carrier revealed no variants. Germline/tumor whole exome sequencing for this carrier revealed germline variants of unknown significance in ATM and FANCI genes and, in four BRAF-V600E metastases, somatic loss of the MITF wild-type allele, amplification of MITF-E318K and deletion of a 9p21.3 chromosomal region including CDKN2A and MTAP. In silico analysis of tumors from MITF-E318K melanoma carriers in the TCGA Pan-Cancer-Atlas dataset confirmed the association with BRAF mutation and 9p21.3 deletion revealing a common genetic pattern. MTAP was the gene deleted at homozygous level in the highest number of patients. These results support the utility of both germline and tumor genome analysis to define tumor groups providing enhanced information for clinical strategies and highlight the importance of melanoma prevention programs for MITF-E318K patients.

Keywords